In addition, Meng and Qiu reported that human BM-MSC-derived exosomal miR-320a suppressed CXCL9 expression by synoviocytes from RA patients, which resulted in attenuation of synoviocyte activation and RA-induced inflammation [158]. This evidence concerns the gene CXCL9 and rheumatoid arthritis.